Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-

Recalled April 6, 2022 · FDA recall D-0736-2022 · Aurolife Pharma

Hazard

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room. · FDA Class II

Units

4080 bottles

Sold at

Nationwide in the USA and Puerto Rico

Description

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Product

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.

Manufacturer(s)

Aurolife Pharma, LLC

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →